Oncology Flashcards
Describe the commonest haematological malignancy in childhood
- Name and subtypes
- Common genetic abboration
- Typical patient characteristics
- Proportion of childhood cancers
Acute lymphoblastic leukaemia (ALL)
- Particularly B cell lineage (B-ALL): 75% of cases
Causes:
- most commonly t(12;21)
- Ph+ t(9,22)(poor prognostic marker)
Age: Bimodal peak- 2.5years old and 50 year olds
Race: White
Gender: 58% males
Accounts for 30% of childhood cancer cases
Which factors increase risk of ALL?
- FHx
- Down syndrome +++ (20x)
- Previous exposure to chemotherapy, benzenes, radiation
State the three types of leukaemias seen in children
- ALL (80%) of cases
Remaining 20% is AML and ANLL (Acute non-lymphoid leukaemia)
How would a child present with ALL?
Cancer signs: pallor, anorexic, fatigued, lethargic, loss of appetite
Bone marrow invasion --> Thrombocytopenia: easy bruising, prolonged bleeding, epistaxis, mucotanenous bleeding (petechiae) Anaemia: pallor, tiredness, flow murmur Neutropenia: reccurent infections Bone pain
Reticulo-endothelial infilitation–>
Hepatosplenomegaly, parotid infltration, testicular enlargement, thymus enlargement–> DYSPNOEA
Metastasis–>
Meningism, headache, vomiting, cranial nerve palsies
Lymphadenopathy
Overall insidious onset
What investigations would you do on a query leukaemia patient?
What would you expect to find?
FBC: pancytopenia/ leukocytosis
Coagulation screen: 10% have DIC
Blood film: pancytopenia, few blasts, normocytic anaemia
Bone marrow aspiration: >20% lymphoblasts on smear
Flow cytometry:
B-ALL: Tdt, CD10+, CD19+
T-ALL: Tdt, CD2+, CD8+
Other tests:
- LP if worried of CNS involvement
- CXR: mediastinal mass (T-ALL)
Name 5 poor prognostic features for ALL
Age <1 or >10 High tumour burden: MLL rearrangement t(4,11) or t(9,22) Hypodiploidy Detectable minimal residual disease (MRD) after induction therapy Extramedullary disease
What are the general management principles for ALL
- Remission induction
- First correct anaemia, treat infections and transfuse platelets
- Steroids + chemotherapy
- Allopurinol to protect kidneys from damage from increased cell lysis due to chemo
- Hydration - Intensification
- High dose chemotherapy
- Increased risk of toxicity - Continuous therapy
- Low intensity therapy for 1-3 years
What alternative management strategies can be used in ALL for those with refractory/relapsing disease?
- High dose chemotherapy + total body irradiation
- Bone marrow transplantation
- CAR-T therapy (B-ALL)
- Imatinib or other TKIs (If Ph+)
Describe 3 complications of chemotherapy in ALL
- Tumour lysis syndrome: hypERkalaemia, hypERphosphataemia, hypERuraemia, hypOcalcaemia
- Myelosuppression: eradication of RBC, WBCs and platelets leading to their diminished functions systemically e.g. neutropenic sepsis
- Infertility (particularly male)
Describe 2 complications of ALL
Extramedullary involvement
CNS- seizures
Cardiac- arrhythmias
Renal failure
Infertility
What is a Wilms tumour?
A nephroblastoma that arises within the kidney and distorts its internal architecture
- commonest childhood renal tumour
- tends to be unilateral (5% bilateral)
Which syndromes are associated with Wilms tumour?
- WAGR (Wilms tumour, Aniridia, Genitourinary anomalies and mental retardation)
- Denys-Drash syndrome (congential nephropathy, Wilms and disorders of sexual development in males)
- Beckwith-Weidemann (overgrowth and cancer predisposition)
- Hemihypertrophy
What is the commonest genetic aberration in Wilms?
WT1 deletion (in 30% of cases) - Tumour suppressor gene
WT2
Describe a patient presenting with Wilms
2-5 years old
Abdominal mass (+/- distension, flank pain) Painless, microscopic haematuria
HTN, anorexia, anaemia,
How does palpation of a Wilms tumour differ to that of a neuroblastoma?
Wilms tumour: smooth palpable mass that doesnt extend past midline
Neuroblastoma: firm, irregular shaped mass that crosses the midline